Cite
Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab
MLA
Ryusuke Ninomiya, et al. “Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.” Internal Medicine (Tokyo, Japan), vol. 61, no. 15, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....55792c3db35748b0e765290bf2533be3&authtype=sso&custid=ns315887.
APA
Ryusuke Ninomiya, Yuhei Kinehara, Satoshi Tobita, Hachiro Konaka, Ryu Jokoji, Takashi Shintani, & Isao Tachibana. (2022). Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab. Internal Medicine (Tokyo, Japan), 61(15).
Chicago
Ryusuke Ninomiya, Yuhei Kinehara, Satoshi Tobita, Hachiro Konaka, Ryu Jokoji, Takashi Shintani, and Isao Tachibana. 2022. “Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.” Internal Medicine (Tokyo, Japan) 61 (15). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....55792c3db35748b0e765290bf2533be3&authtype=sso&custid=ns315887.